Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib
Titel:
Effect of concomitant dosing with acid-reducing agents and vemurafenib dose on survival in patients with BRAFV600 mutation–positive metastatic melanoma treated with vemurafenib ± cobimetinib
Auteur:
Lewis, Karl Hauschild, Axel Larkin, James Ribas, Antoni Flaherty, Keith T. McArthur, Grant A. Dréno, Brigitte McKenna, Edward Zhu, Qian Mun, Yong Ascierto, Paolo A.